Brain scans aim to uncover early signs of psychosis
NCT ID NCT06977308
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This study uses brain scans to examine dopamine, a key brain chemical, in 115 people aged 18-30 who are at high risk for psychosis. Participants will have PET and MRI scans and be followed for up to two years to see if they develop psychosis. The goal is to understand where and when dopamine becomes abnormal, which could help develop better treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New french test could catch psychosis warning signs earlier in teens
- Mindfulness under the microscope: what it feels like for those at psychosis risk
- Can mindfulness stop psychosis before it starts?
- CBD trial aims to stop psychosis before it starts
- Can online therapy help prevent psychosis in At-Risk youth?
- Brain games for psychosis prevention: a new hope?